#9,666 by institutional money · Stock
CNS Pharmaceuticals, Inc. (CNSP)
Institutional ownership from Q3 2026 Form 13F filings
$3.92
−10.51% today
Market closed. Prices as of Nov 20, 8:11 AM ET
- 13F holders
- 13 (+2)
- Held by 13F filers, live
- $1.2M
- Shares held
- 305,293
- Share of stock outstanding
- 20.7%
- Net buying in Q3 2026
- +$97K
- New positions / sold out
- 2 / 0
Largest holders
13 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Ikarian Capital, LLC | 135,830 | $532K | 0.12% | Unchanged |
| ADAR1 Capital Management, LLC | 70,000 | $274K | <0.1% | Unchanged |
| Stonepine Capital Management, LLC | 39,942 | $156K | 0.16% | Reduced −4% |
| Citadel Advisors LLC Ken Griffin | 19,695 | $77K | <0.1% | New |
| Vanguard Capital Management LLC | 15,760 | $62K | <0.1% | Added +125% |
| Boothbay Fund Management, LLC | 13,524 | $53K | <0.1% | Unchanged |
| Vanguard Fiduciary Trust Co | 10,226 | $40K | <0.1% | Unchanged |
| Tower Research Capital LLC (TRC) | 150 | $587 | <0.1% | Reduced −81% |
| UBS Group AG | 130 | $509 | <0.1% | Reduced −91% |
| FMR LLC | 26 | $102 | <0.1% | New |
| Barrett & Company, Inc. | 8 | $31 | <0.1% | Unchanged |
| Danske Bank A/s | 1 | $4 | <0.1% | Unchanged |
| Barclays Plc | 1 | $4 | <0.1% | Reduced −95% |